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Diabetic retinopathy and age-relatedmacular degeneration are lead-
ing causes of blindness among older adults. Both conditions are more
prevalent among those with chronic kidney disease (CKD). However,
few if any previous examinations of CKD and visual impairment (VI)
have been conducted. This gap in knowledge is ﬁlled by Wong et al.
(2016) in their article published in this issue of EBioMedicine.
The prevalence of VI and associations between CKD, VI and other
major ocular diseases are reported for Asian adults between 40 and
80 years of age participating in the Singapore Epidemiology of Eye
Disease (SEED) Study between 2004 and 2011 (n=9434). Chronic kid-
ney disease (estimated glomerular ﬁltration rate b 60mL/min/1.73m2)
was deﬁned using the Kidney Disease Outcomes Quality Initiative
(KDOQI) Work Group deﬁnition and diagnosis of VI and other major
ocular diseases were based on comprehensive ophthalmological exam-
ination. The prevalence of VI and any ocular disease were signiﬁcantly
higher in those with CKD (36.1% and 84.7%) than in those without
(12.9% and 54.3%). Moreover, CKD was associated with signiﬁcantly
higher risk of VI, any ocular disease, cataracts, any retinopathy and
diabetic retinopathy after adjustment for potential confounders (odds
ratios ranging from 1.24 to 1.94).
This paper makes a valuable addition to the literature because
adequate vision is fundamental to quality of life and many forms of
blindness are treatable and preventable (Wong et al., 2016). One
impressive aspect of the study, apart from the very large sample, is
that multiple eye disease outcomes are presented in a single study
(i.e., those previously mentioned as well as glaucoma). The beneﬁts of
comparing different outcomes within the same study, as compared to
different studies using different samples and methods, are obvious.
The selection and modeling of covariates to adjust for confounders
reﬂects the authors' understanding that “the high occult burden of
ocular disease may be explained in part by risk factors common to
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both eye and kidney disease” (Wong et al., 2016). Themodels represent
an exhaustive list of theoretically and clinically relevant cardiovascular
disease covariates. We were, however, disappointed in the lack of any
variable indexing inﬂammation (e.g., C-reactive protein, but see
Table 1 for an extended list), an important mechanism underlying
CKD and ocular disease, particularly among those with diabetes
mellitus. This is discussed by Wong et al. (2016), although they did
not list it as a limitation of their study. Additionally, late stages of CKD
were examined in relation to VI andocular diseaseswithout considering
physiological complications of treatment that have been previously
identiﬁed (Murray, 2008; Chelala et al., 2015).
1. Future Studies
Future studies will beneﬁt from consideration of inﬂammation as a
common precursor of ocular and kidney disease, especially in individ-
uals with diabetes (Semeraro et al., 2015). There is also a broader con-
text for future studies that promises to tie the literature on visual and
cognitive outcomes together. It is clear that CKD predicts signiﬁcantly
lower levels of cognitive performance, with the worst performance ob-
served for those with the lowest levels of kidney function (Elias et al.,
DOI of original article: http://dx.doi.org/10.1016/j.ebiom.2016.01.023.
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Table 1
Inﬂammatory markers identiﬁed in the cardiovascular literature.
Categories of inﬂammatory markers Inﬂammatory markers
Acute-phase reactants C-reactive protein
Fibrinogen
Serum amyloid A
Adhesion molecules Vascular cell adhesion molecule-1
P-selectin
Intracellular adhesion molecule-1
E-selectin
Cytokines Interleukin-1β
Interleukin-6
Interleukin-8
Interleukin-10
Monocyte chemoattractant protein-1
Tumor necrosis factor-α
Other Mechanisms A2 phospholipases
Erythrocyte sedimentation rate
Matrix metalloproteinases
Myeloperoxidase
Placental growth factor
White blood cell count
http://dx.doi.org/10.1016/j.ebiom.2016.02.010
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2009, 2013; Davey et al., 2013; Torres et al., 2016). Further, visual im-
pairment has been associated with lower levels of performance on cer-
tain cognitive tests in the elderly (Dupuis et al., 2014). This is consistent
with our ﬁnding that tests of cognition most sensitive to CKD are very
often those which require adequate vision to complete (e.g., those
indexing visual–spatial organization and memory) (Torres et al., 2016;
Elias et al., 2009).
However, visual acuity and other indices of visual function are rarely
reported or analyzed as confounders in cognitive studies. Application of
the Wong et al. paradigm (Wong et al., 2016) to studies of cognition
would help us understand the extent to which cognitive deﬁcits in the
elderly are, in part, a reﬂection of poor vision rather than cognitive
impairment.
2. Clinical Importance and Key Message
The Wong et al. study (Wong et al., 2016) is of epidemiological and
clinical signiﬁcance. The prevalence of VI as indexed in those with CKD
is 36%, versus 13% among those without CKD. In the former, the odds
ratio of VI among individuals without diabetes was 1.11 compared to
1.80 among individuals with diabetes. Moreover, the odds ratio of
retinopathy among individuals without diabetes was 1.45 compared
with 1.95 among individuals with diabetes. This is unacceptably high
risk given that CKD, diabetes and eye diseases are treatable and prevent-
able. Screening for ocular diseases in thosewith CKD, especially individ-
uals with diabetes, is warranted. More generally, the Wong et al. paper
(Wong et al., 2016) tells us that eye is not only the window to the
kidney, but also to the brain.
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